Marcello PERSICO

About Marcello PERSICO

Marcello PERSICO, With an exceptional h-index of 57 and a recent h-index of 40 (since 2020), a distinguished researcher at Università degli Studi di Salerno, specializes in the field of Liver Disease Antiviral Therapy. Insulin Resistance and chronic Liver disease.

His recent articles reflect a diverse array of research interests and contributions to the field:

Reduction of the Risk of Hepatocellular Carcinoma over Time Using Direct-Acting Antivirals: A Propensity Score Analysis of a Real-Life Cohort (PITER HCV)

OC. 05.2: FIRST AND FURTHER LIVER DECOMPENSATION IN PATIENTS WITH METABOLIC-DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE: WHAT CLINICAL IMPACT?

Predicting de‐novo portal vein thrombosis after HCV eradication: A long‐term competing risk analysis in the ongoing PITER cohort

Biliary Leak from Ducts of Luschka: Systematic Review of the Literature

Repeated measurements and data integration to monitor and study MASLD patients experiencing weight loss

Steatotic liver in renal transplant recipients does not correlate with CVD, a retrospective cohort study

Characterization by polygenic risk score of a dysmetabolic population of Southern Italy

Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort

Marcello PERSICO Information

University

Position

Professore Associato Medicina Interna

Citations(all)

12606

Citations(since 2020)

5213

Cited By

8838

hIndex(all)

57

hIndex(since 2020)

40

i10Index(all)

158

i10Index(since 2020)

92

Email

University Profile Page

Google Scholar

Marcello PERSICO Skills & Research Interests

Liver Disease Antiviral Therapy. Insulin Resistance and chronic Liver disease

Top articles of Marcello PERSICO

Reduction of the Risk of Hepatocellular Carcinoma over Time Using Direct-Acting Antivirals: A Propensity Score Analysis of a Real-Life Cohort (PITER HCV)

Viruses

2024/4/26

OC. 05.2: FIRST AND FURTHER LIVER DECOMPENSATION IN PATIENTS WITH METABOLIC-DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE: WHAT CLINICAL IMPACT?

Digestive and Liver Disease

2024/4/1

Predicting de‐novo portal vein thrombosis after HCV eradication: A long‐term competing risk analysis in the ongoing PITER cohort

United European Gastroenterology Journal

2023/11/30

Biliary Leak from Ducts of Luschka: Systematic Review of the Literature

2024/2/26

Marcello Persico
Marcello Persico

H-Index: 30

Repeated measurements and data integration to monitor and study MASLD patients experiencing weight loss

Digestive and Liver Disease

2024/2/1

Steatotic liver in renal transplant recipients does not correlate with CVD, a retrospective cohort study

Digestive and Liver Disease

2024/2/1

Characterization by polygenic risk score of a dysmetabolic population of Southern Italy

Digestive and Liver Disease

2024/2/1

Detecting early improvements in a NAFLD patient population during diet-induced weight loss

Journal of Hepatology

2023/6/1

Mario Masarone
Mario Masarone

H-Index: 20

Marcello Persico
Marcello Persico

H-Index: 30

Evaluation of genetic risk score of a dysmetabolic and obese population of southern Italy

Journal of Hepatology

2023/6/1

Mario Masarone
Mario Masarone

H-Index: 20

Marcello Persico
Marcello Persico

H-Index: 30

Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study

Frontiers in medicine

2023/5/25

Intravascular Complications of Central Venous Catheterization by Insertion Site in Acute Leukemia during Remission Induction Chemotherapy Phase: Lower Risk with Peripherally …

Cancers

2023/4/4

Corrigendum to “Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian …

Digestive and Liver Disease

2023/4/1

Corrigendum to ‘Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian …

Nutrition, Metabolism and Cardiovascular Diseases

2023/4/1

T. 11.6 TREATMENT WITH GLECAPREVIR AND PIBRENTASVIR IS SAFE AND EFFECTIVE IN ITALIAN

Digestive and Liver Disease

2023/3/1

NAFLD and weight loss: The Salerno experience on close monitoring

Digestive and Liver Disease

2023/3/1

Genetic characterization of a dysmetabolic and obese population of Southern Italy

Digestive and Liver Disease

2023/3/1

Safety and effectiveness of 8 weeks of Glecaprevir/Pibrentasvir in challenging HCV patients: Italian data from the CREST study

Plos one

2023/2/2

Marcello Persico
Marcello Persico

H-Index: 30

Erica Villa
Erica Villa

H-Index: 29

Ultrasonography‐guided core‐needle biopsy of lymphadenopathies suspected of lymphoma: Analysis on diagnostic efficacy and safety of 1000 front‐line biopsies in a multicenter …

Hematological Oncology

2023/12

See List of Professors in Marcello PERSICO University(Università degli Studi di Salerno)